A brighter future for patients
Our mission is to advance medicines that will provide a brighter future for patients with serious conditions that are not fully served by existing treatments.
Our current focus is brain cancer, including Glioblastoma, Medulloblastoma and Diffuse Midline Glioma.
Leptomeningeal disease is a rare but serious complication of cancer that affects the delicate membranes surrounding the brain and spinal cord.
Receiving a diagnosis of diffuse midline glioma can be a challenging and overwhelming experience for both patients and their carers.
Reports & Presentations